Co-Diagnostics, Inc. (CODX)
2.275
-0.22
(-9.00%)
USD |
NASDAQ |
Mar 17, 16:00
2.25
-0.02
(-1.10%)
After-Hours: 19:41
Co-Diagnostics EPS Diluted (Quarterly) : -4.661 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.887M |
| Revenue (Quarterly) | 0.1454M |
| Total Expenses (Quarterly) | 6.032M |
| Enterprise Value | -4.734M |
| Gross Profit Margin (Quarterly) | -102.0% |
| Profit Margin (Quarterly) | -4.05K% |
| Earnings Yield | -963.2% |
| Normalized Earnings Yield | -963.18 |